SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001626199-24-000059
Filing Date
2024-04-26
Accepted
2024-04-25 19:48:44
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A alpn-20231231.htm   iXBRL 10-K/A 545004
2 EX-31.3 alpn-ex313_20231231.htm EX-31.3 4014
3 EX-31.4 alpn-ex314_20231231.htm EX-31.4 3956
  Complete submission text file 0001626199-24-000059.txt   816912

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20231231.xsd EX-101.SCH 2575
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20231231_lab.xml EX-101.LAB 37707
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20231231_pre.xml EX-101.PRE 22112
19 EXTRACTED XBRL INSTANCE DOCUMENT alpn-20231231_htm.xml XML 5305
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37449 | Film No.: 24878229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)